Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) FCF Margin: 2021

Historic FCF Margin for Atea Pharmaceuticals (AVIR) over the last 1 years, with Dec 2021 value amounting to -39.25%.

  • Atea Pharmaceuticals' FCF Margin was N/A to -39.25% in Q4 2021 from the same period last year, while for Dec 2021 it was -24.76%, marking a year-over-year change of. This contributed to the annual value of -24.76% for FY2021, which is 63486.00% down from last year.
  • Atea Pharmaceuticals' FCF Margin amounted to -39.25% in Q4 2021, which was down 156.97% from 68.89% recorded in Q3 2021.
  • Atea Pharmaceuticals' 5-year FCF Margin high stood at 68.89% for Q3 2021, and its period low was -39.25% during Q4 2021.
  • In the last 1 years, Atea Pharmaceuticals' FCF Margin had a median value of -27.12% in 2021 and averaged -6.15%.